Antiplatelet drugs in the management of patients with thrombotic disorders.
D001157:Arterial Occlusive Diseases / Q000188:drug therapy; D001161:Arteriosclerosis / Q000188:drug therapy; D001241:Aspirin / Q000627:therapeutic use; D001778:Blood Coagulation Disorders / Q000188:drug therapy; D001792:Blood Platelets / Q000187:drug effects*; D002404:Catheterization / Q000009:adverse effects; D002561:Cerebrovascular Disorders / Q000188:drug therapy; D003327:Coronary Disease / Q000188:drug therapy; D004176:Dipyridamole / Q000627:therapeutic use; D005921:Glomerulonephritis / Q000188:drug therapy; D006801:Humans; D013442:Sulfinpyrazone / Q000627:therapeutic use; D013468:Suloctidil / Q000627:therapeutic use; D013876:Thiophenes / Q000627:therapeutic use; D013924:Thrombophlebitis / Q000517:prevention & control; D013927:Thrombosis / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control; D013988:Ticlopidine; D014652:Vascular Diseases / Q000188:drug therapy*; D014656:Vascular Surgical Procedures / Q000009:adverse effects
D013876:Thiophenes; D004176:Dipyridamole; D013988:Ticlopidine; D001241:Aspirin; D013442:Sulfinpyrazone; D013468:Suloctidil